<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Pharmacogenetics of a standard tamoxifen therapy regimen in female breast cancer patients of black African origin in Zimbabwe</title>
  </titleInfo>
  <name type="personal">
    <namePart>Tizora, Phindile Mhlope.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
    <role>
      <roleTerm type="text">author.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Professor Collen Masimirembwa.</namePart>
    <role>
      <roleTerm type="text">supervisor.</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Professor Andrew Hlanganiso Siwela.</namePart>
    <role>
      <roleTerm type="text">supervisor.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="text">Bulawayo, Zimbabwe</placeTerm>
    </place>
    <publisher>National University of Science and Technology</publisher>
    <dateIssued>©2019</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xi, 105 pages : illustrations ; 30 cm.</extent>
  </physicalDescription>
  <note type="statement of responsibility">by Phindile Mhlope Tizora.</note>
  <note>A thesis submitted in partial fulfilment of the requirements for the Master of Philosophy in Applied Biology and Biochemistry.</note>
  <note>Masters</note>
  <note>Includes bibliographical references.</note>
  <subject>
    <topic>Breast Cancer</topic>
    <topic>Patients</topic>
    <geographic>Zimbabwe</geographic>
  </subject>
  <subject>
    <topic>Breast Cancer</topic>
    <topic>Chemotherapy</topic>
    <geographic>Zimbabwe</geographic>
  </subject>
  <subject>
    <topic>Tamoxifen</topic>
    <topic>Therapeutic use</topic>
  </subject>
  <subject>
    <topic>Pharmacogenetics</topic>
    <geographic>Zimbabwe</geographic>
  </subject>
  <subject>
    <topic>Pharmacogenetics</topic>
    <geographic>Africa, Southern</geographic>
  </subject>
  <subject>
    <topic>Personalized medicine</topic>
    <geographic>Zimbabwe</geographic>
  </subject>
  <subject>
    <topic>Women</topic>
    <topic>Health and hygiene</topic>
    <geographic>Zimbabwe</geographic>
  </subject>
  <classification authority="lcc">RC278.7.B7 TIZ</classification>
  <recordInfo>
    <recordContentSource authority="marcorg">NUST</recordContentSource>
    <recordCreationDate encoding="marc">260520</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260520161518.0</recordChangeDate>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
